"Forgotten" Illnesses are More Profitable Than Expected | Drug Discovery And Development
LabRoots,
Why do pharmaceutical companies invest research and money into treating a rare disease when the payout is low? They dont.
Why do pharmaceutical companies invest research and money into treating a rare disease when the payout is low? They dont.
Why do pharmaceutical companies invest research and money into treating a rare disease when the payout is low? They dont.
January 4 marks the anniversary of the Orphan Drug Act, which was enacted in 1983.
Dear Mr. Shkreli and Ms. Retzlaff, I wonder how long it takes Turing Pharmaceuticals to blow through $100,000.